These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 6195900

  • 21. Experimental basis of enhancing the immunogenicity of influenza B virus by genetic recombination.
    Medvedeva TE, Gordon MA, Aleksandrova GI, Smorodintsev AA.
    Acta Virol; 1980 Dec; 24(6):385-90. PubMed ID: 6111198
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Analysis of genome composition and reactogenicity of recombinants of cold-adapted and virulent virus strains.
    Ghendon YZ, Klimov AI, Alexandrova GI, Polezhaev FI.
    J Gen Virol; 1981 Apr; 53(Pt 2):215-24. PubMed ID: 7264609
    [Abstract] [Full Text] [Related]

  • 24. Peculiarities of obtaining attenuated thermosensitive recombinants of influenza A virus at the end of the H3N2 epidemic cycle.
    Polezhaev FI, Garmashova LM, Rumovsky VI, Aleksandrova GI, Smorodintsev AA.
    Acta Virol; 1980 Jun; 24(4):273-8. PubMed ID: 6106378
    [Abstract] [Full Text] [Related]

  • 25. Studies of biological properties of the recombinants between human influenza and fowl plague viruses as related to genome composition.
    Ginzburg VP, Markushin SG, Ghendon YZ.
    Acta Virol; 1982 Dec; 26(6):432-7. PubMed ID: 6132538
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Recombinant cold-adapted attenuated influenza A vaccines for use in children: molecular genetic analysis of the cold-adapted donor and recombinants.
    Ghendon YZ, Polezhaev FI, Lisovskaya KV, Medvedeva TE, Alexandrova GI, Klimov AI.
    Infect Immun; 1984 Jun; 44(3):730-3. PubMed ID: 6724694
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Immunogenicity of attenuated reassortants of influenza A virus /Leningrad/134/47/57 (H2N2) for mice, depending on their genome].
    Egorov AIu, Garmashova LM, Nevedomskaia GN, Bogomolova LI, Khaĭder AM, Aleksandrova GI.
    Vopr Virusol; 1994 Jun; 39(5):198-201. PubMed ID: 7716900
    [Abstract] [Full Text] [Related]

  • 32. Recombination of influenza A virus strains: effect on pathogenicity.
    Ennis FA, Verbonitz M, Reichelderfer P, Daniel S.
    Dev Biol Stand; 1976 Jun; 33():220-5. PubMed ID: 955268
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Live cold-adapted influenza A vaccine produced in Vero cell line.
    Romanova J, Katinger D, Ferko B, Vcelar B, Sereinig S, Kuznetsov O, Stukova M, Erofeeva M, Kiselev O, Katinger H, Egorov A.
    Virus Res; 2004 Jul; 103(1-2):187-93. PubMed ID: 15163508
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Laboratory and clinical characteristics of attenuated strains of influenza virus.
    Maassab HF, Francis T, Davenport FM, Hennessy AV, Minuse E, Anderson G.
    Bull World Health Organ; 1969 Jul; 41(3):589-94. PubMed ID: 5309481
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.